top of page

Scientific Studies and Reports

Ketamine and Esketamine in the News

Scientific American

Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain

The Food and Drug Administration’s approval in March of a depression treatment based on ketamine generated headlines, in part, because the drug represents a completely new approach for dealing with a condition the World Health Organization has labeled the leading cause of disability worldwide.

bottom of page